HOME >> BIOLOGY >> NEWS
Mary Frances Lyon to receive Rockefeller's Pearl Meister Greengard Prize

The third annual Pearl Meister Greengard Prize, an international award to recognize the accomplishments of outstanding women scientists, will be presented to British geneticist Mary Frances Lyon on November 2.

The prize, awarded by Rockefeller University, was established by Paul Greengard, Rockefeller's Vincent Astor Professor and head of the Laboratory of Molecular and Cellular Neuroscience, and his wife, sculptor Ursula von Rydingsvard. Dr. Greengard donated his entire monetary share of the 2000 Nobel Prize in Physiology or Medicine to Rockefeller and, in partnership with generous supporters of the university, created this prize. Named in memory of his mother, the prize was founded in part to acknowledge the struggle faced by women in the sciences and the historical paucity of recognition for their accomplishments.

Dr. Lyon, who spent most of her career in the radiobiology unit of the Medical Research Council in the United Kingdom, is honored for her groundbreaking work in mouse genetics. Trained at Cambridge University, Dr. Lyon's most consequential discovery was the recognition, in 1961, of a fundamental genetic control mechanism called X-chromosome inactivation, also referred to as the Lyon hypothesis, which determined that in mammalian cells with multiple X chromosomes, all but one X chromosome is inactivated during embryogenesis.

Insights gained from Dr. Lyon's discovery have led to significant advances in our understanding of X-linked inherited diseases such as hemophilia, Duchenne muscular dystrophy, fragile X syndrome and certain cancers. Dr. Lyon has also made major contributions to understanding the effects of radiation and other environmental agents on genetic mutation.

"Mary Frances Lyon is an exceptional role model, who worked in science at a time when it was quite difficult for a woman to pursue a career in research. It is a pleasure to recognize her contributions to the field of genetics with the third Pear
'"/>

Contact: Joseph Bonner
bonnerj@rockefeller.edu
212-327-8998
Rockefeller University
30-Oct-2006


Page: 1 2

Related biology news :

1. Carnegie Mellons Peter Adams receives EPA research grant
2. 2007 EURYI: 20 young researchers to receive Nobel Prize-sized awards for breakthrough ideas
3. Fedoroff, of Penn State, to receive National Medal of Science
4. Philadelphia ecologist receives top Mongolia honor
5. Nearly 90 percent of babies receive recommended newborn screening tests
6. VIB scientist receives major research grant
7. Maynard Olson receives $500,000 Gruber Genetics Prize
8. University of Cincinnati receives $1.7M to research molecular treatment of brain injury
9. UGA scientists receive $20M in federal bioenergy initiative
10. Wright State scientist receives grant to help clean up polluted American harbors
11. UCR biologist receives $1.75 million grant to study plant-threatening bacteria

Post Your Comments:
(Date:6/18/2013)... Faculty of Medicine have discovered a mechanism that is ... a component of blood typically associated with clotting, were ... detection, seal it off from the rest of the ... Immunology this week, provide the science community with ... has known that platelets do participate in immunity, but ...
(Date:6/18/2013)... United Kingdom, the Energy Department,s National Renewable Energy ... recently published a paper describing a novel cellulose-degrading ... quadripunctata , commonly known as the gribble. ... a relatively unique ability to produce their own ... down the biomass they eat. New biomass-degrading enzymes ...
(Date:6/18/2013)... A UT Arlington environmental engineer has been awarded ... District to ensure water quality and flow in ... Project. , Andrew Kruzic, UT Arlington associate professor ... and locations to add monochloramine to the water ... the new pump stations and pipelines. Adding monochloramine ...
Breaking Biology News(10 mins):Immunity mechanism discovered 2Novel enzyme from tiny gribble could prove a boon for biofuels research 2UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2
(Date:6/18/2013)... June 18, 2013  AMRI (NASDAQ: ... Burlington, Mass. , site has received approval ... (DEA) registration to handle Schedule 2 and 2N ... of Burlington,s physical security ... (Logo: http://photos.prnewswire.com/prnh/20120229/NY61160LOGO ) ...
(Date:6/18/2013)... ZIONA, Israel , June 18, 2013 /PRNewswire/ ... bulk Active Pharmaceutical Ingredients (APIs), generic and innovative intermediates, and ... today that the company has been granted a ... in the US and Europe for ... Patent number 8,410,176 B2 is titled Intermediate Compounds and ...
(Date:6/18/2013)... This webinar will examine the history ... and review the basic FDA regulations and guiding ... these principles through real world case studies and ... on FDA regulations and guidance related to prescription ... traditional and newer forms of promotional materials for ...
(Date:6/18/2013)... , June 18, 2013 ... ) has announced the addition of the ... [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & ... & Auto Injectors] & Therapeutics [Diabetes & ... report to their offering.      ...
Breaking Biology Technology:AMRI Burlington Receives DEA Approval to Handle Controlled Substances 2Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2Drug Advertising and Promotion Labeling: FDA Regulations, New Webinar Hosted by Xtalks 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 3
Cached News: